Is the retroperitoneoscopic adrenalectomy cheaper than transperitoneal access? A retrospective matched analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030186

Enrollment

Registered

2022-12-22

Start date

2023-02-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D35

Interventions

Group 1: Arm 1: Laparoscopic adrenalectomy retrospective data analysis with the goal to perform a cost analysis, comparing arm 1 (laparoscopic) and arm 2 (retroperitoneoscopic) Group 2: Arm 2: retrope

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: laparoscopic and retroperitoneoscopic adrenalectomy, benign adrenal tumors

Exclusion criteria

Exclusion criteria: malignant adrenal tumor

Design outcomes

Primary

Measure	Time frame
Revenue/costs retrospective collection of the costs (total cost analysis) and revenue (DRG revenue) of treatment after the patient has been discharged. The survey is carried out using the hospital software ISH (SAP) by electronic query. Data will be collected retrospectively at the end of 2022 for patients treated between 2018 and 2021.	—

Secondary

Measure	Time frame
Morbidity, mortality, hospitalization	—

Countries

Germany

Contacts

Public ContactFranck Billmann

Universitätsklinikum Heidelberg

franck.billmann@med.uni-heidelberg.de062215634411

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026